Get started
Author

Rita de Cássia Costamilan

Observed names: R. De Cassia Costamilan, RC Costamilan, Rita De Cassia Costamilan, Rita de Cassia Costamilan, Rita de Cassia Costamilan Rit Rita de Cassia Costamilan, Rita de Cassia Costamillan
Observed institutions: AC Camargo Hospital, Universidade de Caxias do Sul, Hospital Moinhos de Vento, Hospital Araújo Jorge, Instituto Nacional de Câncer - INCA, Universidade Federal de Goiás
OpenAlex ID: A5012957918
Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
2022 · Thomas Powles, Piotr Tomczak, et al. · The Lancet Oncology · 310
PDF
The impact of sociodemographic factors and health insurance coverage in the diagnosis and clinicopathological characteristics of breast cancer in Brazil: AMAZONA III study (GBECAM 0115)
2020 · Daniela Dornelles Rosa, José Bines, et al. · Breast Cancer Research and Treatment · 80
Advanced Stage at Diagnosis and Worse Clinicopathologic Features in Young Women with Breast Cancer in Brazil: A Subanalysis of the AMAZONA III Study (GBECAM 0115)
2019 · Maria Alice Franzoi, Daniela D. Rosa, et al. · Journal of Global Oncology · 64
PDF
Bempegaldesleukin Plus Nivolumab Versus Sunitinib or Cabozantinib in Previously Untreated Advanced Clear Cell Renal Cell Carcinoma: A Phase III Randomized Study (PIVOT-09)
2024 · Nizar M. Tannir, Maria Nirvana Formiga, et al. · Journal of Clinical Oncology · 36
Single-Agent Divarasib in Patients With KRAS G12C –Positive Non–Small Cell Lung Cancer: Long-Term Follow-Up of a Phase I Study
2025 · Adrian G. Sacher, Wilson H. Miller, et al. · Journal of Clinical Oncology · 35
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
2021 · Dmytro Trukhin, Elena Poddubskaya, et al. · BioDrugs · 27
PDF
Multicenter Database of Patients with Germ-Cell Tumors: A Latin American Cooperative Oncology Group Registry (LACOG 0515)
2022 · Diogo A. Bastos, Aline Bobato Lara Gongora, et al. · Clinical Genitourinary Cancer · 12
PDF
OA14.06 Divarasib Single-Agent Long-Term Follow-up and Atezolizumab Combination Treatment in Patients with KRAS G12C-Positive NSCLC
2024 · A. Sacher, W.H. Miller, et al. · Journal of Thoracic Oncology · 7
PDF
Germline Genetic Testing in Breast Cancer: Utilization and Disparities in a Middle-Income Country
2025 · Alessandra Borba Anton de Souza, Carlos Barrios, et al. · JCO Global Oncology · 4
PDF
Abstract CT022: Divarasib plus migoprotafib combination treatment in patients with KRAS G12C-positive non-small cell lung cancer (NSCLC)
2025 · Jia Luo, Adrian Sacher, et al. · Cancer Research · 3
Cancer survival (SURVCANCER BRAZIL): Analysis of 132,621 cases from 19 hospital-based registries in southernmost Brazilian state comparing public and private insurance.
2023 · Juliana Giacomazzi, Fernando Cotait Maluf, et al. · Journal of Clinical Oncology · 2
Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohort
2026 · Júlio César Prestes, Gustavo Viani, et al. · Cancer Treatment and Research Communications · 1
Abstract P1-08-29: Current status of clinical and pathological characteristics of breast cancer patients in Brazil: Results of the AMAZONA III study (GBECAM 0115)
2019 · D Rosa, C Barrios, et al. · Cancer Research · 1
Survival After Multimodal Treatment for Breast Cancer in Brazil: The Predominant Role of Clinical Stage and Treatment Response
2026 · Júlio Cesar Prestes, Andre Guimares Gouveia, et al. · Clinical Breast Cancer
Abstract P3-01-07: Breast Cancer Survival According to Health Insurance Coverage in Brazil: Results from the Prospective AMAZONA III Study (GBECAM 0115)
2025 · Daniela Dornelles Rosa, José Bines, et al. · Clinical Cancer Research
Determinants of Delayed Postoperative Radiation Therapy in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy in Brazil
2025 · Júlio César Prestes, Gustavo Arruda Viani, et al. · SSRN Electronic Journal
Determinants of Delayed Postoperative Radiation Therapy in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy in Brazil
2025 · Júlio César Prestes, Gustavo Arruda Viani, et al. · SSRN Electronic Journal
Estimated Costs of Cervical Cancer Care in a Public Reference Hospital
2019 · Samara Piccoli, Juliana da Silva Irias Cavalheiro, et al. · Brazilian Journal of Oncology
Relatos Desafiadores De Neoplasia Colorretal Em Gestantes
2018 · Eduardo Brambilla, Alesandra Bassani, et al. · Journal of Coloproctology
Recorrência De Neoplasia Renal Como Trombo Tumoral Venoso Exclusivo – Relato De Caso
2017 · Rafael Maciel Grochot, Patrícia Moretto, et al. · Brazilian Journal of Oncology
Induction chemotherapy with cisplatin plus weekly paclitaxel followed by concurrent chemoradiotherapy in locally advanced squamous cell carcinoma of the head and neck (LASCCHN): Single center experience in the south of Brazil.
2015 · Janaina Brollo, Sargeele Silva, et al. · Journal of Clinical Oncology
Works count: 21
Citation count: 580
H-index: 7
I10-index: 7
Year
Topic
Type